SEPPIC Launches SEPIBLISSTM, the First Nutricosmetic Ingredient Dedicated to Reactive Skin


Paris, France - May 15th, 2018
At Vitafoods 2018, in Geneva, SEPPIC has launched SEPIBLISSTM, the first nutricosmetic active ingredient dedicated to reactive and sensitive skins.

Today 50% of the population is concerned by sensitive skin. This phenomenon is global and growing due to multiple aggressions such as pollution, weather conditions, emotional stress or food habits. SEPIBLISSTM is the solution to handle this concern in a new innovative way, by soothing these reactions by oral route.

Once formulated in a dietary supplement, SEPIBLISSTM offers the advantage to soothe in just a simple gesture the feelings experienced by  reactive and sensitive skins  (irritations, redness, ...) on the face and the whole body.

SEPIBLISSTM answers the current expectations of the consumer: natural solutions, traceability and local sourcing. Made  without additive,  SEPIBLISSTM is a 100% virgin  coriander seed oil, extracted without solvent and manufactured locally in the South West of France. SEPIBLISSTM is also the first nutraceutical active ingredient with dedicated studies on the different mechanisms involved in skin reactivity phenomenon. Its skin soothing activity has been demonstrated with an  in vitro model. This product fits SEPPIC’s strategy of designing innovative, natural and eco-responsible ingredients.

Claire NOTIN, Marketing Manager Nutrition: "We are proud to propose the first nutraceutical active ingredient designed specifically for sensitive skins. This launch confirms the pioneer role of SEPPIC in nutricosmetics, supported by our expertise in skin biology and our knowledge of the cosmetic market.”

Seppic in brief
A subsidiary of the Air Liquide group in the Healthcare business, Seppic creates and markets a wide range of specialty ingredients for health and beauty . Present in 100 countries through its subsidiaries and its network of distributors, Seppic employs 700 people worldwide, including 100 employees dedicated to innovation.

Air Liquide Healthcare
supplies medical gases, home healthcare services, hygiene products, medical equipment and specialty ingredients. In 2017, it served over 15,000 hospitals and more then 1.5 million patients at home throughout the world. The Group’s Healthcare business reached € 3,401 million in revenues in 2017, with the support of its 16,500 employees.

« back